Harvard scientist behind Justin Bieber’s NAD therapy resigns, leaving China’s booming anti-ageing industry in hot water
Back in April that year, Li’s private venture capital firm Horizons Ventures ploughed US$25 million into Nasdaq-listed ChromaDex. According to Frank Jaksch, co-founder and chairman of ChromaDex, Li has been …
